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A B S T R A C T
Objectives: Patients with cystic fibrosis are characterized by an increased risk of nutrient malabsorp-
tion and inflammation, which may influence body composition. We examined the differences in body
composition between patients with cystic fibrosis and healthy controls and how body composition dif-
ferences may impact disease risk and mortality.
Methods: Three different electronic databases (PubMed, Web of Science, and Embase) were used to find
articles from inception until March 2017. The search strategy excluded articles that reported data on an-
thropometric measures only such as body weight, height, or waist circumference. Information on the
characteristics of the study populations (e.g., age, sex, body mass index), type of study design, body com-
position methods, body compartments, and health outcomes was extracted.
Results: Thirty-nine articles were included in the systematic review. The total number of patients with
cystic fibrosis and controls that were included in these studies was 1839 and 2178, respectively. Only
one study explored the association between body composition and risk of mortality whereas the ma-
jority of the studies examined the association between body composition and respiratory function (33%).
Patients with cystic fibrosis had less fat-free mass and bone mineral density compared with the con-
trols and fat-free mass was associated with decreased inspiratory muscle strength.
Conclusions: Patients with cystic fibrosis may be at an increased risk of sarcopenia and osteopenia. The
measurement of body composition could improve the assessment of nutritional status and reduce the
risk for respiratory and metabolic complications in patients with cystic fibrosis.
© 2018 Elsevier Inc. All rights reserved.
Introduction
Cystic fibrosis (CF) is an inherited disease that is caused by
recessive mutations in the cystic fibrosis transmembrane con-
ductance regulator gene, which cause altered transport of chloride,
bicarbonate, and sodium ions across the epithelial cell mem-
branes [1]. The phenotypic manifestations of this dysfunction
are abnormal fluid transport and accumulation of thick mucus
in different organs such as the liver, pancreas, intestines, and
lungs [2].
Patients with CF are affected by a range of respiratory and gas-
trointestinal problems including airway inflammation and
increased susceptibility to repeated infections, exocrine pancre-
atic insufficiency andmalabsorption, and a chronic inflammatory
status that leads to general malaise and a poor quality of life [3].
Patients with CFmay have a reduced level of physical activity (PA)
and increased resting energy expenditure, which is often exac-
erbated by pulmonary complications, increased fecal energy loss,
and reduced food intake that is caused by inflammation-related
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anorexia. All these factors may contribute to the increase in risk
of malnutrition [4].
The mechanisms that explain the increase in resting energy
expenditure are still unclear and could be associated with the se-
verity of pancreatic insufficiency and lung inflammation [5]. The
risk of malnutrition could also be increased by fecal energy losses
as a result of malabsorption. The incremental transit of unpro-
cessed food in the intestine may further intensify the
malabsorptive syndrome as a consequence of bacterial intesti-
nal overgrowth and low bicarbonate output [6]. The resulting
negative energy balance that is derived from a reduced appe-
tite and increased energy needs contributes to the risk of
deterioration of the nutritional status of patients with CF [7].
Body composition can be assessed using various methods that
provide quantitative and qualitative information on various tissue
components such as fat-free mass (FFM), fat mass (FM), total body
water (TBW), bone mineral density (BMD), and bone mineral
content (BMC). These methods are all characterized by advan-
tages and disadvantages that can affect the precision and accuracy
of the body composition assessment, the applicability in clini-
cal or research settings, and most importantly the provision of
specific information on body components.
In 2015 the UK CF Trust Registry Report found that 12.4% of
children and adolescents with CF were below the 10th percen-
tile weight-for-age and sex and themedian bodymass index (BMI)
in adults age 18 to 40 y was 22.4 kg/m2 [8]. The careful moni-
toring of growth trajectories and nutritional status is a key priority
in the multidisciplinary care of patients with CF. The poor nu-
tritional status of patients with CF is associated with a
deterioration of their quality of life and may accelerate the clin-
ical progression of the disease [9]. Several studies have shown
a close association between malnutrition and a decline in lung
function [10,11].
There is a growing body of literature in support of the im-
portance of the assessment of nutritional status in patients with
CF to improve diagnostic and therapeutic health care pathways
[12,13]. This systematic review aims to examine the differences
in body composition between patients with CF and healthy con-
trols and discuss how these differences may impact survival and
clinical endpoints such as impaired lung function and recurrent
infections.
Methods
Search strategy
The systematic review was conducted in accordance with the Preferred Re-
porting Items for Systematic Reviews and Meta-Analyses guidelines [14]. The
PubMed, Web of Science, and Embase databases were searched by one re-
searcher (PC) from their inception to March 2017.
The following terms were included in the search strategy: (cystic fibrosis OR
cftr) AND (body composition OR nutritional status); AND (fat mass or fat free
mass OR adiposity OR lean body mass OR muscle mass OR hydration OR body
water OR body cell mass OR bone mineral content OR bone mineral density OR
osteopenia OR osteoporosis). Only articles in the English language and studies
that were conducted in humans were selected. In addition, a manual search of
the reference lists was carried out to find additional studies.
Two investigators (MS and PC) independently reviewed the titles and ab-
stracts to identify eligible studies and any doubts over eligibility were resolved
by discussion until a consensus was reached between the authors.
Inclusion criteria and data extraction
The inclusion criteria that were applied to this systematic review were: 1)
Research that was published in the English-language; 2) assessment of body com-
position in patients with CF; and 3) comparison of the body composition of patients
with CF with those of healthy controls. Duplicate publications were excluded from
the review. We also excluded studies that evaluated body composition by mea-
suring only weight, height, or waist circumference.
Data from eligible studies were independently extracted using a standard-
ized form. The following informationwas collected: First author, year of publication,
type of study, sample size, description of study population (i.e., age, sex, race,
and country of study), method of body composition measurement, description
of body composition (i.e., weight, height, BMI, FFM, FM, TBW, BMD, and BMC),
pulmonary function (forced expiratory velocity in 1 s [FEV1] or percent of pre-
dicted values [FEV1%]), main aims, and findings of the selected studies.
Study quality assessment
The quality of the studies was measured using the Downs and Black item
checklist [15], which is a recommended instrument by the Cochrane Collabora-
tion for use in observational and non-randomized studies [16]. We omitted seven
questions from the original checklist because these items were specific to
interventional trials. Two extra items (#14 and #15) were added because they
reviewed the quality of the methods that were used to evaluate body composi-
tion and the body compartments that were analyzed. The final checklist included
15 items with a maximum score of 15 points (range, 0–15) with the higher points
indicating superior quality (Supplementary Table S1). The tool assesses quality
criteria such as a clear description of the aims, interventions, participants, outcome
measurements, and quality of the statistical analyses. Studies were indepen-
dently appraised by two reviewers (LMD and PC). A cutoff point of nine was
adopted in this systematic review to categorize studies as high (≥9) or low (<9)
quality.
Results
Search results
The search of the electronic databases identified 8788 poten-
tially relevant studies. After removing duplicate studies, 1850
studies were initially reviewed on the basis of an assessment of
the titles and abstracts against the eligibility criteria. A total of
1523 articles failed to meet the inclusion criteria and were ex-
cluded from the review. The remaining 327 full-text articles were
assessed for eligibility and 39 studies were included in the final
review. Figure 1 summarizes the screening and selection process.
Description and quality of the studies
Among the 39 included studies, two were longitudinal [17,18]
and the remaining 36 studies had a cross-sectional design
(Table 1). All studies included a healthy control group. The total
number of patients with CF and controls was 1839 and 2178, re-
spectively. The age range of the subjects was different between
the studies: Nine studies recruited subjects age <10 y [18,22,40]
and 10 studies included subjects age 10 y to 20 y [17,39,49] but
the majority of the studies were conducted in adult popula-
tions (18 studies: age ≥20 y; Table 1). Only one study recruited
both children and adults [26].
The studies that were included in the systematic review had
different aims: 1) Evaluation of the relationship between body
composition and clinical outcomes (lung function [19,22,39,48,54],
inflammation [4,21,23,45], clinical parameters [21,25–27,32], or
disease severity [28,34,36,38,47]; and 2) validation or compar-
ison of different techniques to evaluate the differences in body
composition between patients with CF and healthy controls
[17,20,41,50,51,53] or comparison of changes in growth and/or
nutritional status between subjects with and without CF
[18,33,37,42,52]. Finally, two studies explored the association
between resting energy expenditure and body composition in pa-
tients with CF (Table 1) [40,49].
The average value from the Downs and Black quality evalu-
ation was 8.8 ± 2.1. A total of 21 studies had a score ≥9 and 18
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studies had a score <9. The minimum and maximum total scores
were 5 and 12, respectively (Supplementary Table S2).
Body composition differences between subjects with and without
cystic fibrosis
Fat-free mass
Six studies showed a lower FFM, lean body mass (LBM), or
muscle mass in patients with CF compared with healthy sub-
jects [19,33,36,38,42,44] but four papers did not find a significant
difference between the two groups [43,45,47,52]. Two studies in
children concluded that patients with CF gained less FFM during
the follow-up period than the controls [18,21] but four studies
found no significant difference between the two groups
[43,45,47,52]. A significant association was reported between low
LBM, loss of diaphragm muscle mass [29], and impaired inspi-
ratory muscle function [34]. One study also found that patients
with CFwho had low FFMwere less active than those with normal
FFM (Table 2) [35].
Fat mass
Four studies reported a similar FM in patients with CF com-
pared with healthy controls [19,36,43,45,52] but two studies
reported a comparable FM% in the presence of an increased central
fat accumulation in patients with CF [43,45]. Seven studies re-
ported a lower FM in patients with CF compared with healthy
controls [18,23,30,33,42,44,54], but only two of these studies were
in adult populations [30,44] (Table 3).
Total body water
Three studies measured TBW and reported that a large pro-
portion of children with CF were considered dehydrated [22]. One
study compared bioelectric impedance analysis measurements
of TBW to deuterium dilution and found a significant agree-
ment between the two methods in subjects with and without CF
[20] but another study found that bioelectric impedance analy-
sis overestimated TBW in patients with CF but not in controls [46]
(Table 4).
Bone mineral density/content
A reduced BMD or BMC was found in patients with CF com-
pared with controls: Two studies reported a low BMD at all sites
(i.e., lumbar spine [L2-L4], femoral neck, Ward’s triangle) [30,33]
and two studies evaluated the differences of tibial and radial BMD
[25,27], but one study reported that hip BMDwas reduced in pa-
tients with a normal BMI and low FFM [36]. Kelly et al. [37]
concluded that the BMC deficit was related to an altered body
size (i.e., short stature and low LBM) because the differences
between patients and controls disappeared if BMC was cor-
rected for these two variables [28]. On the other hand, three
studies did not find any difference in BMD and BMC between pa-
tients with CF and controls whowerematched for age, sex, height,
and LBM [21,26,32]. All these studies used dual-energy x-ray
absorptiometry or peripheral quantitative computed tomogra-
phy to assess body composition (Table 5).
Body composition and clinical endpoints
Respiratory function
Thirteen studies analyzed the relationship between pulmo-
nary function and body composition. Three studies found a higher
impairment of lung function in patients with CF who had lower
BMD [35,36,39]. Nine studies reported a significant association
between low FEV1 and low FFM or LBM [4,19,38,43,48], which
was exacerbated by a low BMI [34,36] or poor inspiratory muscle
work capacity [29]. The association between FEV1 and FM was
Fig. 1. Flow diagram for Preferred Reporting Items for Systematic Reviews and Meta-Analyses systematic review.
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Table 1
Main characteristics and aim of the of 39 studies that were selected for the systematic review
Reference Study
design
CF/healthy
controls
Age (y) Aim of the study
Alvarez et al. [19] Pilot CS 32/20 CF: 26.1 ± 8.9 Evaluate the relationship between lung function and body composition and examine the presence of
normal weight obesity.C: 30.9 ± 8.8
Azcue et al. [20] CS 20/21 CF: 21.2 ± 9.1 Validate BIA as a measure of TBW.
C: 21.5 ± 8.6
Bai et al. [21] CS 12/24 CF: 11.8 ± 0.9 Examine BMC and BMD and investigate geometric bone properties of children with CF compared with
healthy controls.C: 12.4 ± 0.9
Barbieri et al.
[22]
CS 46/24 CF: 8.5 Examine the association of nutrition and hydration status with lung function.
C: 8.8
Boguszewski
et al. [23]
CS 26/33 CF: 8.52 ± 2.98 Evaluate the relationships between disease activity, body composition, IGF-1, and leptin
concentrationsC: 8.76 ± 1.75
Borowitz et al.
[24]
Pilot CS 10/10 CF: 27 Compare BIA to isotope dilution in patients with CF and control.
C: 27.5
Brookes et al.
[25]
CS 53/53 CF: 12.5 ± 1.6 Assess volumetric BMD as well as bone and muscle parameters using pQCT.
C: 11.8 ± 1.58
Buntain et al.
[26]
CS 153/149 CF: Range, 5.3–55.8 Examine the relationship between BMD and clinical parameters including physical activity, nutrition,
and vitamin D levels.C: Range, 5.6–48.3
De Meer et al.
[17]
L 26/13 CF: 14.7 ± 2 Study applicability of the SFt method to measure changes in body composition after home exercise
training and assess the validity of SFt compared with DDC: 15.2 ± 1.9
Donovan et al.
[27]
CS 30/30 CF: 30 ± 2 Examine the relationships between BMD, anthropomorphic variables, pulmonary status,
glucocorticoid therapy, and vitamin D concentrations.C: 32 ± 2
Elkin et al. [28] CS 25/25 CF: 28 ± 8 Determine the relationship between muscle mass and strength, muscle, and bone mass and the
quality of CF muscle.C: 28 ± 7
Enright et al. [29] CS 40/30 CF: 22.4 Investigate the effect of loss of FFM on pulmonary function, physical activity, and diaphragm
thickness.C: 21.7
Gray et al. [30] CS 22/65 CF: 23 ± 8 Determine whether osteopenia occurs in adults with CF and delineate clinical and biochemical
predictors of BMD.C: 26 ± 6
Gruet et al. [31] CS 15/15 CF: 28 ± 6 Determine whether patients with CF with mild-to-moderate lung disease have altered skeletal muscle
contractility and greater muscle fatigability compared with healthy controls.C: 28 ± 5
Hardin et al. [32] CS 28 adults, 16
children/17
adults
CF: 25 ± 5 adults;
11 ± 1 children
Measure BMD in non-acutely ill adults and BMC in children with CF.
C, 25 ± 4 adults
Henderson and
Madsen [33]
CS 47/40 CF: 11.9 ± 4.0 Assess the interrelationships between various measures of growth including height, weight, and bone
density and the bone mineral, lean, and fat body compartments.C: NR
Ionescu et al.
[34]
CS and
survival
49/25 CF: 22.9 ± 3.8 Determine the effect of BMI and LBM depletion on handgrip force and inspiratory muscle function.
C: NR
Ionescu et al.
[35]
CS 22/22 CF: 23.6 Determine the relationships between host inflammatory response, body composition, bone protein
turnover, and catabolic status.C: 23.8
Ionescu et al. [4] CS 40/22 CF: 23.1 Study the relationships between severity of lung disease, body composition, host inflammatory
response, dietary intake, and evidence of cellular and connective tissue protein breakdown.C: 23.8
Ionescu et al.
[36]
CS 56/20 CF: 23 Determine the occurrence and distribution of hidden FFM loss and its relationship to indicators of
disease severity.C: 23.6
Kelly et al. [37] CS 82/322 CF: 13.2 ± 2.9 Characterize BMC in children with CF and determine the relationship to growth, body composition,
and disease severity.C: 12.9 ± 2.9
King et al. [38] Prospective
CS
86/156 CF: 30.0 ± 7.7 Determine the prevalence of FFM depletion, compare FFM index with BMI, and identify predictors of
FFM depletion.C: NR
Lucidi et al. [39] CS 82/82 CF: 13.5 ± 5.6 Investigate the correlation between severity of the clinical condition, bone status, and body
composition parameters.C: 12.9 ± 5.9
Marin et al. [40] CS 15/15 CF: 8.2 ± 3.8 Assess REE, nutrition status, and body composition of clinically stable outpatients with CF.
C, 7.9 ± 3.2
McNaughton
et al. [41]
CS 226/140 CF: 8.76 ± 5.54 Compare standard anthropometric measurements and TBK as indicators of malnutrition.
C: NR
Miller et al. [42] CS 9/8 CF: 9.3 Investigate nutritional growth retardation, body composition, and muscle protein catabolism.
C: 10.3
Moriconi et al.
[43]
CS 24/24 CF: 30.4 ± 9.4 Compare body composition and serum adiponectin levels of patients with CF with those of healthy
controls and examine whether LBM or serum concentrations of inflammatory mediators are
associated with disease severity.
C: 30.5 ± 8.8
Newby et al. [44] CS 8/8 CF: 27.3 ± 3.4 Contrast body composition as estimated by densitometry, BIA, TOBEC, SFt, and DD of patients with CF
with the body composition of individuals without CF.C: 28.4 ± 3.5
Panagopoulou
et al. [45]
CS 43/27 CF: 20.2 ± 8.4 Examine serum adiponectin levels and the association with nutritional status and body composition.
C: 19.9 ± 9.4
Richards et al.
[46]
CS 36/42 CF: 25.5 ± 5.6 Compare the measurement of TBW by DD and BIA and determine the intraindividual differences
between methods for both groups.C: 25.4 ± 4.8
Salamoni et al.
[47]
CS 14/14 CF: 12.2 ± 3.5 Assess BMC in well-nourished patients and seek a correlation with FFM.
C: 12.3 ± 3.5
Sheikh et al. [48] CS 208/390 CF: 12.4 ± 3.85 Assess associations of BMI and DXA-derived measures of LBM and FM with lung function.
C: 11.9 ± 3.55
Shepherd et al.
[49]
CS 30/18 CF: 13.07 ± 0.55 Determine whether REE is related to either nutritional status or pulmonary function.
C: 12.56 ± 1.25
Spicher et al. [50] CS 39/39 CF: 12.9 ± 4.4 Compare BIA values to other values obtained by anthropometry and the urinary creatinine excretion
method.C: 12.1 ± 4.3
Stettler et al. [18] L 25/26 CF: 7.8 ± 1.3 Compare changes in growth, body composition, and nutritional status between children with and
without CF.C: 7.7 ± 1.3
Swisher et al.
[51]
Pilot CS 10/10 CF: 22.2 ± 8.5 Compare skinfold and NIR measurements of body composition with ADP measurements.
C: 21.5 ± 2.0
Tomezsko et al.
[52]
CS 23/24 CF: 7.8 ± 1.3 Compare body composition by various methods and identify patterns of growth, FFM, and FM.
C: 7.7 ± 1.1
Williams et al.
[53]
CS 26/122 CF: 9.84 ± 0.9 Evaluate the level of agreement between DXA and the 4CM reference method.
C: 11 ± 3.06
Williams et al.
[54]
CS 85/85 CF: 9.41 ± 1.27 Compare healthy children and children with CF using the 4CM and examine associations between
body composition and lung function.C: 9.43 ± 1.43
4CM, four-component model; ADP, air displacement plethysmography; BIA, bioelectric impedance analysis; BMC, bone mineral content; BMD, bone mineral density; BMI, body mass
index; C, controls; CF, cystic fibrosis; CS, cross-sectional design; DD, deuterium dilution; DXA, dual-energy x-ray absorptiometry; FFM, fat-free mass; FM, fat mass; L, longitudinal design;
IGF-1, insulin-like growth factor 1; LBM, lean body mass; NIR, near-infrared reactance; NR, not reported; pQCT, peripheral quantitative computed tomography; REE, resting energy ex-
penditure; SFt, skinfolds thickness; TBK, total body potassium; TBW, total body water; TOBEC, total body electrical conductivity.
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examined in two studies: One study found a significant posi-
tive association in girls only [54] but the second study reported
an inverse association between lung function and FM (adjusted
for age, sex, and BMI) [19].
Physical activity level
Nine articles evaluated PA level using different tools such as
the Wilson questionnaire [55], which was used in three studies
[30,35,36]; Baecke questionnaire [56], which was used in two
studies [31,38]; and Crocker questionnaire [57], which was used
in one study [26]. One study asked parents about their child’s PA
level [54].
One study showed no significant correlation between PA levels
and BMD [30]. One study reported a lower PA level in adults with
CF than healthy controls [26] but no differences between the two
groups were observed in another study [31]. The prevalence of
sedentary behavior was 86.6% in patients with CF [40] and pa-
tients with less FFM were less physically active than those with
normal FFM [4,35,36]. However, two studies reported a lack of
correlation between body composition and PA level [38,54].
Muscular strength
One study tested the quadricep and hamstring isometric and
isokinetic strength in adults with CF and matched healthy
Table 2
Main findings about FFM in case-control studies on CF
First author name Techniques Results on FFM Main findings of the study
Alvarez et al.
[19]
ADP FFM index was lower in patients with CF with respect to
the reference group (P < 0.01). FEV1% predicted was
positively associated with FFM index (β = 6.31 ± 2.93;
P = 0.04).
Excess adiposity, particularly in the form of NWO, was
inversely associated with lung function in CF.
Bai et al. [21] pQCT CF group had a trend of lower LBM per height (P < 0.08).
Boguszewski
et al. [23]
DXA Shwachman-Kulczycki score was the strongest predictor
of LBM.
Children with CF remain at a high risk of malnutrition and
growth failure.
De Meer et al.
[17]
SFt SFt measurements are applicable to monitor FFM
irrespective of clinical severity of the disease.
Repeated SFt measurements at intervals of 6 mo are applicable
to monitor changes in FFM during exercise training.
Elkin et al. [28] DXA SFt Both muscle strength and muscle mass (total body and
leg) were decreased in CF with respect to controls.
Adults with CF are significantly weaker than controls due to
lower muscle mass and not to a reduced force-generating
capacity of the muscle.
Enright et al.
[29]
DXA Loss of FFM is associated with loss of diaphragm muscle
mass.
There is a relationship between loss of inspiratory muscle
work capacity, FFM, PAS, and pulmonary function.
Henderson and
Madsen [33]
DXA SFt LBM was reduced with a mean deficit of 11.9 ± 2.4%.
Ionescu et al.
[35]
DXA Subjects with a low FFM were more catabolic and less
active than those with a normal FFM.
Chronic pulmonary infection in adults with CF may be a
contributory factor in the long-term complications of low
weight and bone disease.
Ionescu et al.
[36]
BIA DXA Patients had a lower total FFM than healthy subjects
(P < 0.01).
Hidden depletion of FFM was associated with increased loss of
BMD and systemic inflammatory activity.
Ionescu et al.
[34]
SFt There was a significant association between low LBM,
impaired inspiratory muscle function, and reduced HG
force.
A clear relationship between body composition and
impairment of inspiratory muscle function was observed.
Kelly et al. [37] DXA BMC deficit was related to reduced LBM. BMC deficit was related to reduced pulmonary function.
King et al. [38] DXA FFM depletion was found in 14% of adults with CF but
undetectable by BMI in 58% of these patients.
One association of FFM index with FEV1% was found.
Miller et al. [42] SFt Children with CF had a significant deficit of FFM. Children with CF had a significant deficit of body mass
(P < 0.001) including in muscle mass (P < 0.005).
Moriconi et al.
[43]
DXA FFM% was similar in patients and controls. Decreased LBM and increased highly sensitive C-reactive
protein levels were independently associated with worse lung
function.
Newby et al. [44] BIA DD SFt
TOBEC UWW
Densitometry and BIA suggested that reduced CF weights
were due to LBM (10.7, 9.5, and 10.4 kg). TOBEC SFt and
DD indicated that patients with CF had less LBM than
controls and less fat (5.4 kg and 3.6 kg) and less lean
(5.2 kg and 7 kg) tissue.
Densitometry by underwater weighing is unsuitable to assess
the body composition of patients with CF.
Panagopoulou
et al. [45]
BIA CT Patients with CF and controls had comparable FFM%. Patients with malnutrition tended to have a more central fat
distribution with increased visceral adipose tissue.
Salamoni et al.
[47]
BIA DXA Anthropometry, BIA, and DXA showed that FFM was
similar both groups.
Bone mineral content was strongly correlated with fat-free
mass.
Sheikh et al. [48] DXA LBM index was more strongly associated with pulmonary
function than BMI (particularly in male subjects).
Spicher et al.
[50]
BIA SFt FFM was linearly correlated to the resistance index. Regression equations of BIA were similar for both patients
with CF and healthy subjects.
Stettler et al. [18] DD SFt TOBEC FFM increases were slower in boys with CF than in
controls.
Statural growth of boys with CF was slower than that of the
control subjects (P = 0.004) but the differences were less
striking for girls.
Tomezsko et al.
[52]
DD SFt TOBEC FFM not differ significantly between the two groups. The majority of the methods demonstrated that the CF group
achieved normal growth and body composition with a
possible trend of fat depletion.
ADP, air displacement plethysmography; BIA, bioelectric impedance analysis; BMC, bone mineral content; BMD, bone mineral density; CF, cystic fibrosis; CT, com-
puter tomography; DD, deuterium dilution; DXA, dual-energy x-ray absorptiometry; FEV1%, forced expiratory volume in 1 s percentage; FFM, fat-free mass; HG, hand-
grip; LBM, lean body mass; NWO, normal weight obesity; SFt, skinfolds thickness; PAS, physical activity status; pQCT, peripheral quantitative computed tomography;
TOBEC, total body electrical conductivity; UWW, densitometry by underwater weighing.
Shwachman-Kulczycki score to assess disease severity in CF.
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controls [28]. Patients with CF were significantly weaker than the
controls due to a lower muscle mass but the force-generating ca-
pacity of the muscle appeared similar. Indices of muscle
contractility appeared reduced in patients with CF compared with
the controls but the difference disappeared after adjustment for
muscle area, which explained a similar tolerance to fatigue in both
groups [31].
Mortality
One study analyzed the association of body composition in
patients with CF and mortality over a 20-mo follow-up period
[34]. The study assessed body composition using skinfolds and
BMI and showed that a lower baseline BMI was associated with
a greater risk of mortality.
Discussion
Summary of main findings
The majority of the studies reported significant differences in
body composition (i.e., FFM, TBW, and BMD) between patients
with CF and healthy controls. A consistent, significant associa-
Table 3
Main findings about FM in case-control studies on CF
First author name Techniques Results on FM Main findings of the study
Alvarez et al.
[19]
ADP FM index and FM% did not differ between patients with CF
and the reference group. FEV1% predicted was inversely
associated with FM index (β = −6.44 ± 2.93; P = 0.04).
Excess adiposity, particularly in the form of NWO, was
inversely associated with lung function in CF.
Boguszewski
et al. [23]
DXA FM standard deviation score, leptin concentration, and
IGF-1 SDS were lower in children with CF compared with
controls.
Children with CF remain at a high risk of malnutrition and
growth failure.
Gray et al. [30] DXA FM was reduced by 30% compared with normal young
adults.
BMI was positively correlated with BMD at four sites and
disease severity negatively correlated with BMD at two sites.
Henderson and
Madsen [33]
DXA SFt The deficit in FM was nearly as great, averaging
18.1% ± 5.3%.
Ionescu et al.
[36]
BIA DXA Patients had similar FM as healthy subjects. In adults with CF, apparent or hidden loss of FFM rather than
weight loss was related with overall disease severity. Hidden
depletion of FFM was associated with increased loss of BMD
and systemic inflammatory activity.
Miller et al. [42] SFt Children with CF had a significant deficit of FM. Children with CF had a significant deficit of body mass
(P < 0.001) including muscle mass (P < 0.005).
Moriconi et al.
[43]
DXA FM% was similar but central fat accumulation was
increased (trunk to extremity fat; P = 0.01) in patients
compared with controls.
Decreased LBM and increased highly sensitive C-reactive
protein levels were independently associated with worse lung
function.
Newby et al. [44] BIA DD SFt
TOBEC UWW
TOBEC SFt, and DD indicated that patients with CF had less
FM than controls. Densitometry estimates of FM were not
correlated (r < 0.74; P > 0.05) with any other method for
patients with CF but correlated with all other methods for
control subjects.
Densitometry by underwater weighing is unsuitable to assess
the body composition of patients with CF.
Panagopoulou
et al. [45]
BIA CT Patients with CF and controls had comparable FM%. Patients with malnutrition tended to have a more central fat
distribution with increased visceral adipose tissue.
Sheikh et al. [48] DXA FM index was not associated with pulmonary function.
Stettler et al. [18] DD SFt TOBEC FM increase was slower in boys with CF than in controls. Over the 3 y of the study, the statural growth of boys with CF
was slower than that of control subjects (P = 0.004). The
differences in the pattern of changes in growth and body
composition were less striking for girls.
Tomezsko et al.
[52]
DD SFt TOBEC FM does not differ significantly between the two groups
when only using DD. FM% differed between the groups
(P < 0.05).
The majority of the methods demonstrated that the CF group
achieved normal growth and body composition with a
possible trend of fat depletion.
Williams et al.
[54]
ADP DD DXA
SFt
Girls with CF had significantly less FM than healthy girls
even after adjustment for height and pubertal status.
FM in girls was positively associated with FEV1%.
ADP, air displacement plethysmography; BMC, bone mineral content; BMD, bone mineral density; BMI, body mass index; BIA, bioelectric impedance analysis; CF,
cystic fibrosis; CT, computer tomography; DD, deuterium dilution; DXA, dual-energy X-ray absorptiometry; FEV1%, forced expiratory volume in 1 s percentage; FFM,
fat-free mass; IGF-1, insulin-like growth factor 1; LBM, lean body mass; NWO, normal weight obesity; pQCT, peripheral quantitative computed tomography; SDS,
standard deviation scores; SFt, skinfolds thickness; TOBEC, total body electrical conductivity; UWW, densitometry by underwater weighing.
Table 4
Main findings about TBW in case-control studies on CF
First author name Techniques Results on TBW Main findings of the study
Azcue et al. [20] BIA H218O MRA of H218O space versus anthropometric measurements
in both patients with CF and C subjects showed that
weight and height were significant predictors of TBW.
The BIA predictive equation used in healthy controls
cannot be used for patients with CF.
Barbieri et al. [22] BIA SFt 43% of patients with CF were severely/mildly dehydrated
but none were in the controls (P = 0.007).
Patients with CF exhibited a compromised nutrition status
as assessed by anthropometric and BIA parameters that
were also associated with lung function.
Richards et al. [46] BIA DD TBW predicted from BIA was significantly different from
TBW as measured using 2H2O in patients with
CF (P < 0.05) but not in controls.
In CF, BIA overpredicted TBW as determined by 2H2O
dilution to an increasing extent at larger TBW volumes.
2 H2O, heavy water; BIA, bioelectric impedance analysis; C, controls; CF, cystic fibrosis; DD, deuterium dilution; H218O, water isotope; MRA, multiple regression
analysis; SFt, skinfolds thickness; TBW, total body water.
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tion was found between low FFM (or LBM) and impaired
respiratory function in patients with CF. Lower PA levels andmus-
cular strength were associated with lower LBM and associations
were stronger in patients with CF compared with the controls.
All studies were cross-sectional except for one longitudinal study
that found a significant association between low BMI and in-
creased risk of mortality in patients with CF.
Lean body or fat-free mass
Dual-energy x-ray absorptiometry was the most frequently
applied method to measure LBM and showed that patients with
CF have a significantly reduced LBM compared with controls. This
may have important diagnostic and prognostic implications in
patients with CF at risk or with signs of malnutrition [5]. Mal-
nutrition is commonly assessed using simple measurements such
as body weight or BMI and is closely associated with impaired
pulmonary function and muscle performance, which empha-
size the importance of an early identification of patients at risk
of malnutrition [34,58,59]. Enright et al. [29] found a signifi-
cant association between low FFM in patients with CF and the
severity of pulmonary disease, which was related to a loss of di-
aphragm muscle mass. Recent criteria by the European Society
of Clinical Nutrition and Metabolism for patients with chronic
obstructive pulmonary disease advocate for a more integrated
diagnostic approach that combines weight loss with either age-
adjusted BMI or FFM index [60]. Specifically, adults with a normal
BMI and low FFM have a lower predicted FEV1% than adults with
both normal BMI and FFM [36]. This finding underlines once again
the limits of BMI as a marker of nutritional status in complex dis-
eases such as CF [38].
Impaired pulmonary function was consistently associated with
lower FFM in the studies that were included in the systematic
review. Two interpretations are possible, both realistic and not
mutually exclusive: 1) Patients with a worse pulmonary func-
tion and a more severe stage of the disease are characterized by
a reduced appetite, which increases the risk of malnutrition and
FFM loss; or 2) poor nutritional status in patients with CF may
contribute to the deterioration of pulmonary function due to the
inadequate performance of respiratory muscles and an in-
creased risk of infections. However, longitudinal studies are clearly
needed to clarify the relationship between FFM and pulmonary
function in patients with CF.
Bone health
Studies have consistently reported a deficit of BMC and BMD
in patients with CF compared with healthy controls. Factors that
may affect bone health in patients with CF are still largely
unknown but possible causes may include a dysregulation of the
calcium-vitamin Dmetabolism and glucocorticoid-induced bone
mobilization, which could be exacerbated by the presence of
chronic inflammation.
The loss of LBM and bone could be mitigated in patients
with CF by PA [61]. However, only a small number of studies
that were included in this systematic review had evaluated PA
levels in patients with CF. One study revealed a lower level of
PA in patients with CF than controls [26] and the other three
studies found that patients with CF and a lower FFM were less
active [4,35,36].
The relationship between BMD and physical activity was evalu-
ated only by one study and showed no significant correlation
between PA levels and BMD [30]. In addition, these studies used
self-reported questionnaires to evaluate PA, which may not be
entirely appropriate because they have not been validated in popu-
lations with CF.
Finally, a recent position statement [62] highlighted this lack
of evidence because no studies have evaluated physical fitness
Table 5
Main findings about BMD/BMC in case-control studies
First author name Techniques Results on BMD/BMC Main findings of the study
Bai et al. [21] pQCT Children with CF have similar tBMC relative to lean mass as
controls.
Cortical bone area and bone strength were less in the CF
group compared with controls.
Brookes et al. [25] pQCT At puberty, the CF cohort had less BMC at 4% tibia. Pubertal
female patients with CF had a lower bone strength (SSI) at
the tibia (P = 0.00) and radius (P = 0.05) sites.
Bone strength parameters were not compromised before
puberty in this CF cohort. At puberty, several deficits were
present compared with the controls; however, bone
strength adapted to the mechanical demands of the muscle.
Buntain et al. [26] DXA TBK BMD was not significantly different in children age 5 y to 10
y with CF compared with controls.
In children/adolescents, BMD was weakly associated with
nutritional status and disease severity.
Donovan et al. [27] DXA Patients with CF had significantly reduced BMD at the
lumbar spine, total hip, and femoral neck. The radius was
significantly less demineralized than the other sites.
Vertebral fractures were present in 19% of subjects and 41%
had a confirmed history of previous fracture.
Elkin et al. [28] DXA SFt BMD is reduced in patients with CF compared with controls.
When corrected for height, the differences disappeared.
Adults with CF were significantly weaker than controls,
mainly due to lower muscle mass rather than a reduced
force-generating capacity of the muscle.
Gray et al. [30] DXA Patients with CF had significantly reduced tBMD at all sites
compared with normal young adults.
BMI was positively correlated with BMD at four sites and
disease severity was negatively correlated with BMD at two
sites.
Hardin et al. [32] DXA There was no difference in tBMD and BMC between adults
with CF and controls matched for LBM, height, age, and sex.
There was no correlation between pulmonary function
results and BMC.
Henderson and
Madsen [33]
DXA SFt There were significant deficits in tBMD with a mean deficit
of 19.1 ± 3.0% in patients with CF relative to the matched
controls.
Ionescu et al. [36] BIA DXA BMD at hip sites were less in patients with normal BMI and
low FFM compared with those with a normal BMI and FFM
(all P < 0.01).
Hidden depletion of FFM was associated with increased loss
of BMD and systemic inflammatory activity.
Kelly et al. [37] DXA BMC deficit was related to altered body size. BMC deficit was related to reduced pulmonary function.
BIA, bioelectric impedance analysis; BMC, bone mineral content; BMD, bone mineral density; BMI, body mass index; CF, cystic fibrosis; DXA, dual-energy x-ray
absorptiometry;FM, fat mass; FFM, fat-free mass; LBM, lean body mass; pQCT, peripheral quantitative computed tomography; SFt, skinfolds thickness; SSI, stress-
strain index; TBK, total body potassium; tBMC, total bone mineral content; tBMD, total bone mineral density.
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and exercise performance using more accurate instruments such
as accelerometers or standardized exercise tests to date.
Fat mass
The evidence gathered from the systematic review was not
able to provide a coherent message across the studies on the dif-
ferences and roles of FM in patients with CF. The majority of the
studies were conducted in children and reported a lower FM in
childrenwith CF comparedwith healthy controls; however, studies
that were conducted in adult populations found no differences
for FM between the two groups. These discrepant results could
be due to differences in sample size, age, and body composition
techniques that were used to evaluate FM.
Another explanation could be the energy cost of growth that
may account for the reduced FM in children with CF. The energy
that is expended in the synthesis of new tissues is a substantial
component of the total requirement for energy (5–6 kcal/g of body
weight gained), which results in large variations in growth rate
and also the composition of the accrued tissue [63]. Two studies
reported an increased central fat accumulation in patients with
CF despite that FM% was comparable with those of the healthy
controls [43,45].
Limitations
The systematic review included only studies that had a control
group as part of the study design; hence, studies that evaluated
body composition in patients with CF only were not included.
Our primary aim was to understand the changes in body com-
position in patients with CF, which could only and precisely be
assessed if comparedwith a reference healthy group of individuals.
Finally, the large heterogeneity of the study designs, subject
characteristics, and application of body composition tech-
niques has to be taken into account for the interpretation of the
results and validity of the associations between body composi-
tion and clinical outcomes.
Conclusions
Patients with CF, in this study, both adults and children, ap-
peared to be characterized by a decrease in FFM and BMD. In
addition, a decrease in FFMwas consistently associated with im-
paired pulmonary function. The role of FM in patients with CF
was left undefined because inconsistent results were found
between the studies.
The results of the present review confirm the role of body com-
position in predicting the health outcomes of patients with CF.
However, this evidence is predominantly from cross-sectional
studies and longitudinal studies are clearly needed to provide
more robust evidence on the causal associations between body
composition and health outcomes in patients with CF.
Supplementary data
Supplementary data related to this article can be found at
https://doi.org/10.1016/j.nut.2018.03.052.
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